taxonomy (1)
protein (1)
source (3)
structure (0)
composition (42)
disease (2)
reference (3)
site (2)
peptide (2)
- Homo sapiens (Human)
Taxonomy
- CD44 antigen / Homo sapiens P16070
Protein
Reported structure
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 (avg mass : 2386.1655 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 (avg mass : 2371.1942 )
- Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2573.3611 )
- Hex:5 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2428.2462 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:3
- Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1
- Hex:6 HexNAc:5 dHex:3 NeuAc:2
- Hex:6 HexNAc:5 dHex:4 (avg mass : 2591.4167 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:6 HexNAc:6 NeuAc:3 (avg mass : 3083.8134 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:8 HexNAc:7 (avg mass : 2737.5195 )
- Hex:8 HexNAc:7 NeuAc:1
- Hex:9 HexNAc:8 NeuAc:1
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
Reference
- CD44 antigen / Homo sapiens
Reported glycosite
- QIDLNITCR (9aa)
- AFNSTLPTMAQMEK (14aa)
Mass spectrometry observed peptide
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 dHex:2 / N-Linked (avg mass : 1933.7933)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked (avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:4 dHex:2 / N-Linked (avg mass : 2095.9357)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2135.9602)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- CD44 antigen / Homo sapiens
- QIDLNITCR (9aa)
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2282.1032)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:2 / N-Linked (avg mass : 2299.1307)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 / N-Linked (avg mass : 2371.1942)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:7 HexNAc:6 / N-Linked (avg mass : 2372.1821)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 / N-Linked (avg mass : 2386.1655)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2428.2462)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:3 / N-Linked (avg mass : 2445.2737)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:7 HexNAc:6 dHex:1 / N-Linked (avg mass : 2518.3251)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2573.3611)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:4 / N-Linked (avg mass : 2591.4167)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:8 HexNAc:7 / N-Linked (avg mass : 2737.5195)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:6 NeuAc:2 / N-Linked (avg mass : 2792.5555)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked (avg mass : 2881.6465)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 2938.6985)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:6 NeuAc:3 / N-Linked (avg mass : 3083.8134)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3229.9564)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:8 HexNAc:7 NeuAc:1 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
-
- Hex:9 HexNAc:8 NeuAc:1 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- CD44 antigen / Homo sapiens
- AFNSTLPTMAQMEK (14aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
